{"id":32695,"date":"2023-08-29T00:26:23","date_gmt":"2023-08-29T00:26:23","guid":{"rendered":"https:\/\/www.goodacademic.com\/blog\/questions\/assessing-and-treating-vulnerable-populations-for-depressive-disorders-therapy-for-patients-with-major-depressive-disorder-mdd\/"},"modified":"2023-08-29T00:26:23","modified_gmt":"2023-08-29T00:26:23","slug":"assessing-and-treating-vulnerable-populations-for-depressive-disorders-therapy-for-patients-with-major-depressive-disorder-mdd","status":"publish","type":"questions","link":"https:\/\/www.goodacademic.com\/blog\/questions\/assessing-and-treating-vulnerable-populations-for-depressive-disorders-therapy-for-patients-with-major-depressive-disorder-mdd\/","title":{"rendered":"ASSESSING AND TREATING VULNERABLE POPULATIONS FOR DEPRESSIVE DISORDERS. Therapy for Patients With Major Depressive Disorder (MDD)"},"content":{"rendered":"<p>Insruction are embedded in the attached file,<\/p>\n<div>For this assignment, you will develop a patient medication guide for treatment of depressive disorders in a vulnerable population (your choice for one vulnerable patient population to choose from: children, adolescents, older adults, dementia patients, pregnant women or one not listed of your choice!). Be sure to use language appropriate for your audience (patient, caregiver, parent, etc.). You will include non-copyright images and\/or information tables to make your patient medication guide interesting and appealing. Limit your patient medication guide to 5 pages. You will create this guide as an assignment; therefore, a title page, introduction, conclusion, and reference page are required. You must include a minimum of 3 scholarly supporting resources outside of your course provided resources.<br \/>\nIn your patient guide, include discussion on the following:<\/p>\n<p>\u2022\tDepressive disorder causes and symptoms<\/p>\n<p>\u2022\tHow depression is diagnosed for the vulnerable population of your choice, why is this population considered vulnerable<\/p>\n<p>\u2022\tMedication treatment options including risk vs benefits; side effects; FDA approvals for the vulnerable population of your choice<\/p>\n<p>\u2022\tMedication considerations of medication examples prescribed (see last bullet item)<\/p>\n<p>\u2022\tWhat is important to monitor in terms of labs, comorbid medical issues with why important for monitoring<\/p>\n<p>\u2022\tSpecial Considerations (you must be specific, not general and address at least one for EACH category; you must demonstrate critical thinking beyond basics of HIPPA and informed consent!): legal considerations, ethical considerations, cultural considerations, social determinants of health<br \/>\n\u2022\tWhere to follow up in your local community for further information<br \/>\n\u2022\tProvide 3 examples of how to write a proper pres\u0441r\u0456ption that you would provide to the patient or transmit to the pharmacy. <\/p>\n<p> Support your rationale with a minimum of five academic resources. While you may use the course text to support your rationale, it will not count toward the resource requirement. You should be utilizing the primary and secondary literature.<\/p>\n<p>Reminder: The College of Nursing requires that all papers submitted include a title page, introduction, summary, and references.<\/p>\n<p>\u2022\tStahl, S. M. (2021). Stahl\u2032s essential psychopharmacology: Neuroscientific basis and practical applications (5th Ed.) Cambridge University Press.<br \/>\no\tChapter 6, \u2033Mood Disorders and the Neurotransmitter Networks Norepinephrine and y-Aminobutyric Acid (GABA)\u2033 (pp. 244-282)<br \/>\no\tChapter 7, \u2033Treatments for Mood Disorders: So-Called \u201cAntidepressants\u201d and \u201cMood Stabilizers\u201d (pp. 283-338)<br \/>\n\u2022\tAmerican Psychiatric Association. (2022). Diagnostic and statistical manual of mental disordersLinks to an external site. (5th ed., text rev.). https:\/\/go.openathens.net\/redirector\/waldenu.edu?url\uff1dhttps:\/\/dsm.psychiatryonline.org\/doi\/book\/10.1176\/appi.books.9780890425787<\/p>\n<p>\u2022\tHowland, R. H. (2008a). Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 1: Study design. Journal of Psychosocial Nursing and Mental Health ServicesLinks to an external site., 46(9), 21\u201324. https:\/\/doi.org\/10.3928\/02793695-20080901-06<\/p>\n<p>\u2022\tHowland, R. H. (2008b). Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 2: Study outcomes. Journal of Psychosocial Nursing and Mental Health ServicesLinks to an external site., 46(10), 21\u201324. https:\/\/doi.org\/10.3928\/02793695-20081001-05<\/p>\n<p>\u2022\tLorberg, B., Davico, C., Martsenkovskyi, D., &amp; Vitiello, B. (2019).  Principles in using psychotropic medication in children and adolescents. In J. M. Rey &amp; A. Martin (Eds.), IACAPAP e-textbook of child and adolescent mental healthLinks to an external site.. https:\/\/iacapap.org\/_Resources\/Persistent\/45bdffb25befc353c9f61988e82105029504ab85\/A.7-Psychopharmacology-2019.1.pdf<br \/>\n\u2022\t<\/p>\n<p>Develop a patient medication guide for treatment of depressive disorders in a vulnerable population you selected. \u2022 Depressive disorder causes and symptoms \u2022 How depression is diagnosed for the vulnerable population of your choice\t20 to \u02c317.0 pts<br \/>\nExcellent Point range: 90\u2013100<br \/>\nDiscussion includes Depressive disorder causes and symptoms; Discussion includes how depression is diagnosed for the chosen vulnerable population. The response accurately and clearly explains in detail the specific patient factors that impact decision making when prescribing medication for this patient.<\/p>\n<p> Medication treatment options including risk vs benefits; side effects; FDA approvals for the vulnerable population of your choice \u2022 Medication considerations of medication examples prescribed \u2022 What is important to monitor in terms of labs, comorbid medical issues with why important for monitoring of medications prescribed\t20 to \u02c317.0 pts<br \/>\nExcellent Point range: 90\u2013100<br \/>\nMedication treatment options are discussed including risk vs benefits; side effects; FDA approvals for the chosen vulnerable population; Medication considerations of medication examples prescribed; contains discussion of items important to monitor in terms of labs, comorbid medical issues with why important for monitoring.<\/p>\n<p> Special Considerations (you must be specific, not general and address at least one for EACH category; you must demonstrate critical thinking beyond basics of HIPPA and informed consent!): legal considerations, ethical considerations, cultural considerations, social determinants of health \u2022 Where to follow up in your local community for further information\t20 to \u02c317.0 pts<br \/>\nExcellent Point range: 90\u2013100<br \/>\nSpecial Considerations are discussed and specific, not general and address at least one for EACH category demonstrating critical thinking beyond basics of HIPPA and informed consent: legal considerations, ethical considerations, cultural considerations, social determinants of health. Discussion includes directions for where to follow up in local community for further information.<\/p>\n<p>The medication guide discusses why the chosen population is considered vulnerable. The medications guide language is appropriate for the intended audience (patient, caregiver, parent, etc). The medication guide is interesting and appealing including use of graphics\/tables.\t15 to \u02c313.0 pts<br \/>\nExcellent Point range: 90\u2013100<br \/>\nThe medication guide discusses why the chosen population is considered vulnerable. The medications guide language is appropriate for the intended audience (patient, caregiver, parent, etc). The medication guide is interesting and appealing including use of graphics\/tables.<\/p>\n<p>Provides three examples of how to write a proper pres\u0441r\u0456ption that would be provided to patient and\/or transmitted to pharmacy. Pres\u0441r\u0456ption contains date, medication and strength, amount to be taken, route to be taken, frequency, indication, quantity, refills; providers signature.\t15 to \u02c313.0 pts<br \/>\nExcellent Point range: 90\u2013100<br \/>\nProvides three examples of how to write a proper pres\u0441r\u0456ption that would be provided to patient and\/or transmitted to pharmacy. Pres\u0441r\u0456ption contains date, medication and strength, amount to be taken, route to be taken, frequency, indication, quantity, refills; providers signature.<\/p>\n<p>Written Expression and Formatting\u2014Paragraph development and organization: Paragraphs make clear points that support well-developed ideas, flow logically, and demonstrate continuity of ideas. Sentences are carefully focused\u2014neither long and rambling nor short and lacking substance. A clear and comprehensive purpose statement and introduction are provided that delineate all required criteria.\t5 to \u02c34.0 pts<br \/>\nExcellent Point range: 90\u2013100<br \/>\nParagraphs and sentences follow writing standards for flow, continuity, and clarity. &#8230; A clear and comprehensive purpose statement, introduction, and conclusion are provided that delineate all required criteria.<\/p>\n<p>Written Expression and Formatting\u2014English writing standards: Correct grammar, mechanics, and punctuation; Includes title page and reference page with a minimum of 3 scholarly supporting resources outside of course provided resources. Paper is limited to 5 pages not including title and reference page.\t5 to \u02c34.0 pts<br \/>\nExcellent Point range: 90\u2013100<br \/>\nUses correct grammar, spelling, and punctuation with no errors; Includes title page and reference page with a minimum of 3 scholarly supporting resources outside of course provided resources; Paper is limited to 5 pages not including title and reference page.<\/p>\n<p>\t20 to \u02c317.0 pts<br \/>\nExcellent Point range: 90\u2013100<br \/>\nDiscussion includes Depressive disorder causes and symptoms; Discussion includes how depression is diagnosed for the chosen vulnerable population. The response accurately and clearly explains in detail the specific patient factors that impact decision making when prescribing medication for this patient.<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Insruction are embedded in the attached file, For this assignment, you will develop a patient medication guide for treatment of depressive disorders in a vulnerable population (your choice for one vulnerable patient population to choose from: children, adolescents, older adults, dementia patients, pregnant women or one not listed of your choice!). Be sure to use [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":[],"disciplines":[190],"paper_types":[],"tagged":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/questions\/32695"}],"collection":[{"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/questions"}],"about":[{"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/types\/questions"}],"author":[{"embeddable":true,"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/comments?post=32695"}],"version-history":[{"count":0,"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/questions\/32695\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/media?parent=32695"}],"wp:term":[{"taxonomy":"disciplines","embeddable":true,"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/disciplines?post=32695"},{"taxonomy":"paper_types","embeddable":true,"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/paper_types?post=32695"},{"taxonomy":"tagged","embeddable":true,"href":"https:\/\/www.goodacademic.com\/blog\/wp-json\/wp\/v2\/tagged?post=32695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}